Reducing fibrosis progression of biliary atresia by continuous administration of aducanumab at low dose: A potential treatment
Biliary atresia (BA) is a disease in which the intra- and extrahepatic bile ducts are blocked, leading to cholestatic liver cirrhosis and liver failure. Kasai portoenterostomy (KPE) and liver transplantation are the gold treatment methods since effective medical interventions are lacking. Limited by...
| Main Authors: | , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Churchill Livingstone
2022
|
| Subjects: | |
| Online Access: | View Fulltext in Publisher |